Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 542, pseudogene (RN7SL542P)

Target
RN7SL542P
Molecular classification
Other (Processed pseudogene; not a receptor, enzyme, transporter, or transcription factor)
01

Overview

RNA, 7SL, cytoplasmic 542, pseudogene (RN7SL542P) is a processed pseudogene found in the human genome that is derived from 7SL RNA, the non-coding RNA component of the signal recognition particle (SRP)[1][4][5][7]. Most 7SL-related sequences in human DNA are pseudogenes created through reverse transcription and reintegration of the RNA into the genome[5][7]. These pseudogenes, including RN7SL542P, do not produce functional RNA or protein; instead, they are truncated and generally lack expression or biological activity[1][4][5][7]. Although some pseudogenes in other families can have regulatory or disease roles, there is no published evidence or annotation suggesting a biological, clinical, or therapeutic relevance for RN7SL542P[1][2][4][5].

Other names
RN7SL542P7SL RNA pseudogene 542RNA, 7SL, cytoplasmic 542, pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None established for RN7SL542P; pseudogenes in general may play regulatory roles through acting as competitive endogenous RNAs (ceRNAs) but RN7SL542P has no documented function
04

Disease associations

None described for RN7SL542P specifically
05

Safety considerations

None known; no therapeutic relevance
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 542, pseudogene (RN7SL542P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 542, pseudogene (RN7SL542P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call